DOI QR코드

DOI QR Code

Analysis of Death Causes of In-patients with Malignant Tumors in Sichuan Cancer Hospital of China from 2002 to 2012

  • Wang, Xiao (Sichuan Cancer Hospital & Institute) ;
  • Song, Zheng-Fang (Sichuan Cancer Hospital & Institute) ;
  • Xie, Rui-Meng (Sichuan Cancer Hospital & Institute) ;
  • Pei, Jiao (Sichuan Cancer Hospital & Institute) ;
  • Xiang, Ming-Fei (Sichuan Cancer Hospital & Institute) ;
  • Wang, Huan (Sichuan Cancer Hospital & Institute)
  • Published : 2013.07.30

Abstract

Objectives: To analyze underlying disease, fatality rate and the major causes of death of in-patients with malignant tumors in Sichuan Cancer Hospital. Methods: Clinical data of in-patients from 2002 to 2012 were retrospectively analyzed. Results: The top 10 tumors (82.0%of the total) of the malignant tumors of the in-patients were lung, cervical, esophagus, breast, colorectal, nasopharynx, liver and gastric cancers, lymphomas and ovarian cancers. The overall fatality rate was 2.7% during these eleven years, 3.4% and 2.0% for male and females, respectively with statistical significance for the difference (${\chi}^2$=164.737, P<0.001). The top 10 death causes were lung cancer, liver cancer, colorectal cancer, esophagus cancer, gastric cancer, lymphoma, breast cancer, pancreatic cancer, ovarian cancer and nasopharynx cancer. In-patients with pancreatic cancer had the highest fatality rate (9.6%). There were different ranks of death causes in different sex groups and age groups. Conclusion: Prevention and control work of cancer should be enhanced not only for cancers with high incidence such as lung cancer, esophageal cancer but also for the cancers which have low incidence but high fatality rate, such as pancreatic cancer and gallbladder cancer, which would help to improve the survival rate and quality of life of cancer patients in the future.

Keywords

Malignant tumors;in-patients;disease type;causes of death

References

  1. Chen J (2009). Investigation of malignant tumor among army retired cadres in Chengdu. Med J Nat Def Forces Southwest China, 19, 757-8 (in Chinese).
  2. Chinese Health Yearbook Editing Committee (2010). 2010 Chinese Health Statistics Yearbook. People s Health Publishing House, Beijing 346-75 (in Chinese).
  3. Gao YJ (2007). Disease composition and death cause analysis of 15626 hospitalized patients with malignant tumor. Suzhou Univ J Med Sci, 27, 101-3 (in Chinses).
  4. Hao SH, Zhang AL, He M, et al (2012). Death cause analysis of hospitalized patients in Shanxi Cancer Hospital between 2005 and 2010. Cancer Res Clin, 24, 328-31 (in Chinese).
  5. Li J, Zhang D, Zhang Y, et al (2011). Prevalence and genotype distribution of human papillomavirus in women with cervical cancer or high-grade precancerous lesions in Chengdu, western China. Int J Gynaecol Obstet, 112, 131-4 (in Chinese). https://doi.org/10.1016/j.ijgo.2010.08.010
  6. Liu LL, Ji K, Gao YL, et al (2011). Death cause analysis of malignant tumor in death monitoring points between 2002 and 2007. J Prev Med Inform, 27, 8-10.
  7. National Cancer Institute (2012). 2011 Chinese Cancer Registration Annual Report. People s Health Publishing House, Beijing 1-24 (in Chinese).
  8. Wang X, Wang AR, Fan JC, et al (2012). Analysis of esophageal cancer screening between 2006 and 2011 in Yanting county , Sichuan. Chin J Epidemiol, 33, 784-7 (in Chinese).
  9. Zhou JF, Lin H (2010). Death cause and life reduction analysis of malignant tumor in Dalian between 2004 and 2009. Chin J Public Health, 26, 835-6 (in Chinese).

Cited by

  1. Acute Normovolemic Hemodilution Effects on Perioperative Coagulation in Elderly Patients Undergoing Hepatic Carcinectomy vol.14, pp.8, 2013, https://doi.org/10.7314/APJCP.2013.14.8.4529
  2. Experimental Study on Sustained-release 5-Fluorouracil Implantation in Canine Peritoneum and Para-aortic Abdominalis vol.15, pp.1, 2014, https://doi.org/10.7314/APJCP.2014.15.1.407
  3. Clinical, Laboratory Biomarkers and Imaging Findings of Pancreatic Adenocarcinoma in Iran vol.15, pp.10, 2014, https://doi.org/10.7314/APJCP.2014.15.10.4349
  4. R·β-arrestin·JNK Signaling Module vol.15, pp.2, 2014, https://doi.org/10.7314/APJCP.2014.15.2.1041
  5. In Vitro and in Vivo Antitumor Evaluation of Berbamine for Lung Cancer Treatment vol.15, pp.4, 2014, https://doi.org/10.7314/APJCP.2014.15.4.1767
  6. Role of ERK-MAPK signaling pathway in pentagastrin-regulated growth of large intestinal carcinoma vol.20, pp.35, 2014, https://doi.org/10.3748/wjg.v20.i35.12542
  7. Quality of Life for Patients with Esophageal/Gastric Cardia Precursor Lesions or Cancer: A One-year Prospective Study vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.45
  8. Role of p38 Signaling Pathway in Pentagastrin-Regulated Cell Proliferation of Colorectal Carcinoma Cell Line HT-29 vol.07, pp.06, 2016, https://doi.org/10.4236/jct.2016.76041
  9. Downregulation of RASAL2 promotes the proliferation, epithelial-mesenchymal transition and metastasis of colorectal cancer cells vol.13, pp.3, 2017, https://doi.org/10.3892/ol.2017.5581